with a seven day history of fever (39°C), chills, malaise, increased sweating, hyporexia, and mild dyspnoea. One year before admission he had been diagnosed as having pulmonary tuberculosis and was treated with a regimen of drugs including isoniazid (300 mg/day), streptomycin (1 g/day), and pyrazinamide (600 mg/day). The physical examination at admission showed blood pressure 80/50 mmHg, a mild increase in respiratory rate, mild jaundice, erythematous and descamative plaques on the malar region, non-tender cervical lymphadenopathy, and bilateral pleural effusions. At Antibodies to nDNA were negative by indirect immunofluorescence using Crithidia luciliae as a substrate at 1/10 dilution and by an ELISA. Antibodies to non-histone nuclear antigens (Sm, n-ribonucleoprotein), SS-B/La, Scl-70, PCNA) by a double immunodiffusion method were negative. Serial serum samples were examined for antibodies to total histones and histone complexes by an ELISA as described previously;4 increased antibody activity to total histones especially of the IgA class was detected. When the specificity of the antibodies to histone was studied in more detail IgG and IgA reactivity was detected against the H2A-H2B (dimer) complex, especially when bound to DNA ((H2A-H2B)-DNA) (table) .
With all these features we believed that our patient had signs and symptoms of a lupus-like disease related to the drugs used to treat his tuberculosis. These were then discontinued. The patient was treated with prednisone (20 mg/day) and he showed symptomatic improvement with resolution of the jaundice, lymphadenopathy, pleural effusions, and malaise. The patient was discharged and followed up as an outpatient. In July 1989 the dose of prednisone was tapered to 10 mg/day and one month later discontinued. The binding was enhanced when DNA was complexed to the H2A-H2B antigen. Increased reactivity with the (H2A-H2B)-DNA complex has been observed in serum samples from patients with lupus induced by procainamide and quinidine, but these serum samples were not reactive with DNA alone.' DNA apparently stabilises a protein epitope in the H2A-H2B complex, or the complete epitope is generated by the juxtaposition of histone and DNA.
Interestingly in our patient antibody activity to total histones was unusual in being predominantly IgA and fluctuated during the illness, sugesting that another population of antibodies to histone existed and behaved independently of the treatment with isoniazid. The sudden decrease in the activity of antibodies to total histone may have been the result of the immunosuppressive effect of prednisone, followed by a rebound to pretreatment levels when treatment was discontinued. It is possible that antibodies to histone in this patient are related to idiopathic SLE rather than isoniazid induced lupus. Systemic lupus erythematosus, however, is often associated with renal and neurological disease, antibodies to native DNA, Sm or SS-A/Ro, or both, and low complement levels. None of these features was present in this patient. The highly unusual IgA predominance of the activity of antibodies to total histone might reflect a mono-or oligoclonal antibody related to the underlying leukaemia.
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